中国中药杂志2024,Vol.49Issue(9) :2290-2298.DOI:10.19540/j.cnki.cjcmm.20240221.601

藁本内酯治疗神经系统疾病作用机制的研究进展

Research progress on mechanisms of ligustilide in treatment of nervous system diseases

李喜香 杨萍 张亚会 宋薇 王雪梅 李靖
中国中药杂志2024,Vol.49Issue(9) :2290-2298.DOI:10.19540/j.cnki.cjcmm.20240221.601

藁本内酯治疗神经系统疾病作用机制的研究进展

Research progress on mechanisms of ligustilide in treatment of nervous system diseases

李喜香 1杨萍 1张亚会 1宋薇 1王雪梅 1李靖1
扫码查看

作者信息

  • 1. 甘肃省中医院,甘肃 兰州 730050
  • 折叠

摘要

藁本内酯为伞形科植物当归、川芎挥发油的主要活性成分,属于苯酞类化合物,具有抗炎、镇痛、抗氧化、抗肿瘤、抗动脉粥样硬化、神经保护等多种药理作用,能够改善血脑屏障通透性,在神经退行性疾病和其他神经系统疾病的治疗中具有重要潜力,如阿尔茨海默病、缺血性脑卒中、帕金森病、血管性痴呆、抑郁症等.因此,通过对藁本内酯治疗神经系统疾病的作用机制进行归纳总结,为其药物开发及临床应用提供参考.

Abstract

Ligustilide is the main active component of the volatile oil from Angelica sinensis and Ligusticum chuanxiong in the Um-belliferae family.It is a phthalein compound with anti-inflammatory,analgesic,antioxidant,anti-tumor,anti-atherosclerosis,neuro-protective,and other pharmacological effects.It can improve the permeability of the blood-brain barrier and has important potential in the treatment of neurodegenerative diseases and other nervous system diseases,such as Alzheimer's disease,ischemic stroke,Parkin-son's disease,vascular dementia,and depression.Therefore,the mechanism of ligustilide in the treatment of nervous system diseases was summarized to provide a reference for drug development and clinical application.

关键词

藁本内酯/神经系统疾病/神经退行性疾病/阿尔茨海默病/缺血性脑卒中/帕金森病/血管性痴呆

Key words

ligustilide/nervous system disease/neurodegenerative diseases/Alzheimer's disease/ischemic stroke/Parkinson's disease/vascular dementia

引用本文复制引用

基金项目

甘肃省科技计划(21YF5FA018)

出版年

2024
中国中药杂志
中国药学会

中国中药杂志

CSTPCD北大核心
影响因子:1.718
ISSN:1001-5302
参考文献量76
段落导航相关论文